Financial Daily from THE HINDU group of publications
Tuesday, Jan 22, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Home Page - New Products & Services
Corporate - New Products & Services


Cadila to launch Fosinopril

Our Bureau

NEW DELHI, Jan. 21

CADILA Pharmaceuticals Ltd (CPL) is preparing for a nation-wide launch of Fosinopril, its ACE inhibitor with compensatory dual route.

Fovas, the cardio-vascular drug, launched in Ahmedabad this month, will be rolled out in the rest of the country subsequently. Fosinopril has a dual route of elimination and is cleared both through the liver and kidney.

Send this article to Friends by E-Mail

Stories in this Section
BSES places hurdles in DPC bidding process


Tata Tea Q3 net up at Rs 20.67 cr
Satyam Computer posts 36 pc rise in Q3 net
Scientists deny Pak claims on `infested' wheat
Cadila to launch Fosinopril
DCA relaxes norms for differential voting rights
SEBI panel moots early IPOs by MNCs, banks


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright © 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line